A new study looked at the effect of semaglutide vs. tirzepatide on weight loss over a 72 week period. At the end of the 72 ...

In the past, most targeted drug development efforts relied on single biomarkers, but cancer is far more complex. BostonGene’s ...

Michael Yee, Jefferies senior biotech analyst, joins CNBC's 'Squawk on the Street' to discuss how AI could fuel drug ...

Artificial intelligence and robotics are revolutionizing drug discovery by automating laboratory processes and enabling rapid ...

Midtown-based drug discovery startup GRIN Therapeutics has reached a deal with Angelini Pharma to commercialize its signature ...

Dataome curates, integrates and structures molecular, phenotypic and clinical data from public, private and proprietary ...

Researchers have created a pipeline for discovering unique combinations of molecules that increase the effectiveness of ...

Singapore's national platform for drug discovery and development, has announced the presentation of updated clinical data for ...

The bacteria that cause tuberculosis (TB) may have an "on-off switch" that lets them pause and restart growth, according to a ...

This patent strengthens Renovaro's AI and machine learning intellectual property portfolio by protecting novel methods for ...

According to brokerage Jefferies, the average drug development cycle spans 8 to 10 years, with success rates below 10% and ...

Through the trial, which began in May, the team aims to confirm the safety and efficacy of the treatment, with hopes of ...